The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

The trial compared the combo against the investigator’s choice of tyrosine kinase inhibitor monotherapy in the unresectable or advanced hepatocellular carcinoma patient group. Credit: ...

Abstract: Early screening to improve the survival rate of hepatocellular carcinoma (HCC) patients remains a critical clinical challenge. However, current methods for early cancer detection still lack ...

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed improved ...

The FDA approved the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). This regulatory decision is ...

AN ONGOING CHALLENGE at many cancer centers is accurately identifying the TNM staging of patients for data reporting purposes. This can occur due to the time-consuming task of manually reviewing ...

Symptoms that may indicate end stage liver cancer include increased fatigue, abdominal pain, and jaundice, which is the yellowing of the skin and mucus membranes. If a person is nearing the end of ...

Objective To characterise gut microbiome in patients with hepatocellular carcinoma (HCC) and evaluate the potential of microbiome as non-invasive biomarkers for HCC. Design We collected 486 faecal ...